There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Angie Drakulich was editorial director of Pharmaceutical Technology.

Articles

The United States Pharmacopeial (USP) Convention is pursuing greater collaboration with the US Department of Health and Human Services (HHS), and specifically, the US Food and Drug Administration.

USP Offers HHS Advice and Assistance

Also, recalls for two KV Pharmaceutical subsidiaries; Human Genome Sciences delivers anthrax drug to US Strategic National Stockpile; Akorn president and CEO leaves the company; more...

Company and People Notes: AstraZeneca Announces More Job Cuts; Deirdre Connelly Leaves Eli Lilly for GSK; More...

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

The Federal Trade Commission has filed a complaint in federal district court challenging agreements in which Solvay Pharmaceuticals (Marietta, GA) paid generic drug makers Watson Pharmaceuticals (Corona, CA) and Par Pharmaceutical Companies (Woodcliff Lake, NJ) to delay generic competition to Solvay's branded testosterone-replacement drug "AndroGel," a prescription pharmaceutical with annual sales of more than $400 million, according to an FTC press release.

FTC Files Complaint Against Generic Drug Makers

The US Pharmacopeial (USP) Convention has announced new standards for heparin and glycerin.

USP Announces New Standards for Heparin and Glycerin

Brief pharmaceutical news items for February 2009.

Pharma Capsules

USP <231> Heavy Metals is transitioning toward the incorporation of modern quantitative technologies, but there is still much to be resolved.

Illuminating Heavy Metals Testing

To manage risk properly, industry must understand what it is and how to assess it

There is No Such Thing as Zero Risk

A recent reader poll focused on predictions for the industry's future.

Pharma Forecast

Susan J. Schniepp is a fellow at Regulatory Compliance Associates, Inc. and a member of Pharmaceutical Technology's Editorial Advisory Board.

A new book inspires readers to seek ways to apply NMR spectroscopy to their own purposes.

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes